Massive levothyroxine ingestion in a pediatric patient: case report and discussion

Josephine Ho1, Renee Jackson, David Johnson

  • 1University of Calgary, Calgary, AB. josephine.ho@albertahealthservices.ca

CJEM
|April 29, 2011
PubMed

Insights

Massive levothyroxine overdose in a toddler, though alarming, typically has a benign outcome. Monitoring for potential complications like seizures and arrhythmias is crucial, but recovery is usually complete without long-term effects.

Area of Science:

  • Pediatric Toxicology
  • Endocrinology
  • Emergency Medicine

Background:

  • Levothyroxine is a synthetic thyroid hormone commonly prescribed for hypothyroidism.
  • Overdosing on levothyroxine can lead to thyrotoxicosis, a condition of excess thyroid hormone.

Observation:

  • A 2.5-year-old boy ingested a massive dose of levothyroxine (up to 7.6 mg).
  • Initially asymptomatic, he later presented with fever, tachycardia, and decreased appetite.
  • Laboratory tests revealed significantly elevated free thyroxine (T4) and free triiodothyronine (T3) levels.

Findings:

  • The child experienced symptoms including desquamation, hair loss, and irritability.
  • Elevated free T4 normalized by 12 days post-ingestion.
  • Thyroid-stimulating hormone normalized by 7 weeks post-ingestion, with no long-term sequelae.

Implications:

  • Massive levothyroxine ingestions in children, while serious, often follow a benign clinical course.
  • Close monitoring for potential complications such as seizures and arrhythmias is essential.
  • This case highlights the importance of prompt medical evaluation and management following significant levothyroxine overdose in pediatric patients.

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...